Journals
Publish with us
Publishing partnerships
About us
Blog
Disease Markers
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Disease Markers
/
2021
/
Article
/
Tab 6
/
Research Article
Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer
Table 6
Association between HPD and single or combination immunotherapy.
Monotherapy or combination
Total (
)
Non-HPD (
)
HPD (
)
value
Monotherapy
132
115
17
0.121
Dual-immunotherapy
8
6
2
Combine with chemotherapy/targeted therapy
237
218
19
HPD: hyperprogressive disease.